Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1999-12-29
pubmed:abstractText
Haemangioblastoma of the CNS occurs as a sporadic entity and as a manifestation of the autosomal dominant von Hippel-Lindau disease with the major additional components retinal angioma, renal cancer, and pheochromocytoma. Genetic testing for germline mutations predisposing to von Hippel-Lindau disease has been available since identification of the VHL tumour suppressor gene. The impact of this testing was evaluated in patients with haemangioblastomas seen in this centre.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10567493-1670750, http://linkedlifedata.com/resource/pubmed/commentcorrection/10567493-2642584, http://linkedlifedata.com/resource/pubmed/commentcorrection/10567493-2909683, http://linkedlifedata.com/resource/pubmed/commentcorrection/10567493-3310444, http://linkedlifedata.com/resource/pubmed/commentcorrection/10567493-7670659, http://linkedlifedata.com/resource/pubmed/commentcorrection/10567493-7915601, http://linkedlifedata.com/resource/pubmed/commentcorrection/10567493-8493574, http://linkedlifedata.com/resource/pubmed/commentcorrection/10567493-8929948, http://linkedlifedata.com/resource/pubmed/commentcorrection/10567493-9399847, http://linkedlifedata.com/resource/pubmed/commentcorrection/10567493-9681856, http://linkedlifedata.com/resource/pubmed/commentcorrection/10567493-9829911
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-3050
pubmed:author
pubmed:issnType
Print
pubmed:volume
67
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
758-62
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:10567493-Adolescent, pubmed-meshheading:10567493-Adult, pubmed-meshheading:10567493-Aged, pubmed-meshheading:10567493-Axons, pubmed-meshheading:10567493-Cerebellar Neoplasms, pubmed-meshheading:10567493-Child, pubmed-meshheading:10567493-DNA Mutational Analysis, pubmed-meshheading:10567493-Female, pubmed-meshheading:10567493-Gene Expression Regulation, Neoplastic, pubmed-meshheading:10567493-Genes, Tumor Suppressor, pubmed-meshheading:10567493-Genetic Predisposition to Disease, pubmed-meshheading:10567493-Germ-Line Mutation, pubmed-meshheading:10567493-Hemangioblastoma, pubmed-meshheading:10567493-Hemangioma, pubmed-meshheading:10567493-Heterozygote, pubmed-meshheading:10567493-Humans, pubmed-meshheading:10567493-Kidney Neoplasms, pubmed-meshheading:10567493-Male, pubmed-meshheading:10567493-Middle Aged, pubmed-meshheading:10567493-Molecular Biology, pubmed-meshheading:10567493-Pheochromocytoma, pubmed-meshheading:10567493-Polymorphism, Genetic, pubmed-meshheading:10567493-Retinal Neoplasms, pubmed-meshheading:10567493-Sensitivity and Specificity, pubmed-meshheading:10567493-von Hippel-Lindau Disease
pubmed:year
1999
pubmed:articleTitle
The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
pubmed:affiliation
Department of Nephrology and Hypertension, Albert-Ludwigs- University, Freiburg, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't